0.05Open0.05Pre Close0 Volume201 Open Interest12.50Strike Price0.00Turnover190.15%IV45.09%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0641Delta0.0645Gamma173.00Leverage Ratio-0.0218Theta0.0001Rho11.10Eff Leverage0.0013Vega
MiMedx Stock Discussion
I want more, pls go down for a minute
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx (MDXG.US)$